Analyst firms · Piper Sandler · RAPT
Piper Sandler RAPT price target and rating history
RAPT Therapeutics Inc. (RAPT) · Health Care
Piper Sandler rates RAPT Therapeutics Inc. (RAPT) Overweight with a $95 price target, as of its latest action on Jan 9, 2026. It has published 3 rating actions on RAPT since March 2022, including 0 upgrades and 1 downgrade.
- Current rating
- Overweight
- Price target
- $95
- Median target, all firms
- Too few
- Actions on RAPT
- 3
Piper Sandler price target on RAPT
Every Piper Sandler rating on RAPT
- Jan 9, 2026
- Nov 11, 2024
- Mar 11, 2022
Questions about Piper Sandler and RAPT
- What is Piper Sandler's price target for RAPT?
- Piper Sandler's latest stated price target for RAPT Therapeutics Inc. (RAPT) is $95, from its action on Jan 9, 2026.
- What is Piper Sandler's rating on RAPT?
- Piper Sandler rates RAPT Overweight, a bullish rating, as of Jan 9, 2026.
- When did Piper Sandler last change its view on RAPT?
- On Jan 9, 2026, Piper Sandler starts coverage at Overweight, price target $95.
More RAPT rating histories
All Piper Sandler ratingsRAPT news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.